Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,150 | -21,220 | -18,354 | -10,438 | -5,271 |
| Depreciation Amortization | 113 | 460 | 195 | 39 | 20 |
| Accounts payable and accrued liabilities | -331 | 1,435 | -677 | -359 | -365 |
| Other Working Capital | -802 | 1,990 | 1,657 | -177 | -366 |
| Other Operating Activity | 408 | -975 | 1,087 | 556 | 463 |
| Operating Cash Flow | $-3,762 | $-18,310 | $-16,091 | $-10,378 | $-5,519 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -10 | -10 | -10 | -8 |
| Investing Cash Flow | $-5 | $-10 | $-10 | $-10 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 15,000 | 5,000 | N/A | N/A |
| Common Stock Issued | 54,778 | 70 | 70 | 70 | 49 |
| Other Financing Activity | -703 | -1,190 | -44 | 0 | 0 |
| Financing Cash Flow | $54,075 | $13,880 | $5,026 | $70 | $49 |
| Beginning Cash Position | 15,602 | 20,040 | 20,048 | 20,048 | 20,048 |
| End Cash Position | 65,911 | 15,600 | 8,972 | 9,730 | 14,571 |
| Net Cash Flow | $50,308 | $-4,440 | $-11,076 | $-10,318 | $-5,477 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,762 | -18,310 | -16,091 | -10,378 | -5,519 |
| Capital Expenditure | -5 | -13 | -10 | -10 | -8 |
| Free Cash Flow | -3,767 | -18,323 | -16,101 | -10,388 | -5,526 |